glp 1 and gip Beyond the pancreas: contrasting cardiometabolic actions of GLP1 The pleiotropic effects of GLP-1

A new oral version of Wegovy has been FDA-approved, offering a more affordable and accessible option to injectable GLP-1 medications that have transformed weight loss treatment for millions.

The incretin system has become an important target in the treatment of type 2 diabetes in recent years, and glucagon-like peptide 1 (GLP-1) is of particular interest for its glucose-lowering effects

This analytical review critically examines the evidence surrounding GLP-1 agonists efficacy, safety, and real-world implications for obesity treatment in individuals without diabetes

They are asking different questions: 1) How much did lean mass fall relative to baseline

Research shows that nearly 90% of people with type 2 diabetes also struggle with their weight, and these medications solve both problems at once